Compass Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BOSTON, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based...
Atlas-HRT.com Launches Online TRT and Men’s Health Platform in Florida, as Men Over 40 Look for Clear Answers on Testosterone Therapy